Panitumumab interaction with<scp>TAS</scp>‐102 leads to combinational anticancer effects via blocking of<scp>EGFR</scp>‐mediated tumor response to trifluridine
Yuji Baba(Jikei University Kashiwa hospital), Kazuhide Nakamura(Otsuka (Japan))
Cited by 22
Related Papers
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth
|Molecular Cancer Therapeutics|2004|66
Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy
|International Journal of Radiation Oncology*Biology*Physics|1997|55
Prognostic factors of glottic carcinomas treated with radiation therapy: Value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system
|International Journal of Radiation Oncology*Biology*Physics|2005|42